14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 149 days ( 99.50 % )
Last Price $0.000001 0 %
High/ Low $0.000001 - $0.000001 0%
Chg 7 Days N/A $0.000001 $0.000001
Chg 30 Days N/A $0.000001 $0.000001
Chg 12 mos -99.98 % $0.0045 $0.000001
Trend - 3 mos N/A Width: 0.00000000 %
Trend - 12 mos -86.85 % Width: 126.60 %
Pred. range - 3 mos $0.000001 - $0.000001 0 % - 0 %
Pred. range - 12 mos N/A - $0.00007068 -100.00 % - 6,968.15 %
Short MA avg 3 mos Sell Nov 30, -1 - N/A days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Jan 16, 2024 - 58 days
Short MA avg 12 mos Sell Jan 08, 2024 - 63 days
Long MA avg 12 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 12 mos Sell Nov 30, -1 - N/A days
Pivot Short Buy Apr 05, 2024 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About U.S. Stem Cell, Inc.

U.S. Stem Cell. U.S. Stem Cell, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of autologous cellular therapies for the treatment of chronic and acute heart damage, and vascular and autoimmune diseases in the United States. The company's lead product candidates include MyoCell, a clinical therapy designed to populate regions of scar tissue within a patient's heart with autologous muscle cells or cells from a patient's... USRM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT